CURALEAF INTRODUCES FAST-ACTING NANO GUMMIES AS IT EXPANDS PRODUCT RANGE

Select Nano Gummies Launch in Arizona; Curaleaf and Select Nano Gummies Soon to Expand in Multiple States 

WAKEFIELD, Mass., May 18, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced it was further expanding its product portfolio with the addition of Curaleaf and Select Nano Gummies. Utilizing Nano-emulsion technology, the gel edibles are infused with small, water-soluble cannabinoids that allow for faster, more efficient cannabinoid consumption.

The scientifically developed formula makes the cannabis more bioavailable, which allows for faster absorption and more consistent results than traditional edibles. Due to the precise and calibrated effects, Nano products are an optimal micro dosing solution for those who are looking to try edibles for the first time, or for those seeking alternative forms of consumption.

Select Nano Gummies are available beginning this week at Curaleaf locations across Arizona, and will launch in June in Nevada, California, Colorado and Massachusetts, and in July in Michigan and Maine. Curaleaf Nano Gummies will be available in June in Massachusetts and Maryland. Curaleaf and Select Nano Gummies will be available across eight states by the end of Q2.

“Curaleaf is committed to innovative product development as we strive to provide our customers with a variety of options for their cannabis needs,” said Joe Bayern, President of Curaleaf. “We’re thrilled to launch Curaleaf and Select Nano Gummies. Nano technology is an exciting development, and the first that we have scaled across our brands since acquiring Select in February 2020. This unique product expands our portfolio choice for existing customers, and also provides a great entry point for those looking to try cannabis for the first time.”

The launch of Curaleaf and Select Nano Gummies follows the release of Select Elite Live, a high-potency oil infused with freshly harvested live resin terpenes for strain-specific effects. Elite Live recently became available in Maryland and will be the first Select product available in Connecticut and Massachusetts beginning in June. By Q3, Select Elite Live will be available across the majority of Curaleaf’s network.

Select currently retails in Oregon, California, Nevada, Arizona, Colorado, Michigan and Maryland, and recently expanded to Oklahoma.

About Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading vertically integrated multi-state cannabis operator with a dominant presence on both the East and West coasts of the United States, the largest cannabis market in the world. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Strategically positioned in highly populated, limited-license states, the company currently operates in 17 states with 57 dispensaries, 15 cultivation sites, and 24 processing sites. Curaleaf employs over 2,200 people across the United States.

For more information please visit www.curaleaf.com

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Dan Foley, VP, Finance and Investor Relations
[email protected]

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
[email protected]

FORWARD LOOKING STATEMENTS

This media advisory contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, ” expects” or, “proposed”, “is expected”, “intends”, “anticipates”, ” or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward‐looking statements and information concerning the expansion of Curaleaf and Select products. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed September 23, 2019, which is available under the Company’s SEDAR profile at www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

SOURCE Curaleaf Holdings, Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.